Source: Eur Respir J 2012; 39: 104-111
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yeager M.E., Nguyen C.M., Belchenko D.D., Colvin K.L., Takatsuki S., Ivy D.D., Stenmark K.R.. Circulating fibrocytes are increased in children and young adults with pulmonary hypertension. Eur Respir J 2012; 39: 104-111

Member's Comments

No comment yet.

Related content which might interest you: Distinct patterns of circulating endothelial cells in pulmonary hypertension Source: Eur Respir J 2010; 36: 1284-1293 Year: 2010 Fluorescence activated cell sorting for simultaneous assessment of nine surface markers of circulating endothelial progenitor cells in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Circulating haemopoietic and endothelial progenitor cells are decreased in COPD Source: Eur Respir J 2006; 27: 529-541 Year: 2006 Decreased number of circulating endothelial progenitor cells in patients with emphysema Source: Eur Respir J 2005; 26: Suppl. 49, 441s Year: 2005 Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension Source: Eur Respir J 2011; 37: 1392-1399 Year: 2011 Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results) Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Increased levels of circulating endothelial progenitor cells during exacerbations of COPD Source: Annual Congress 2007 - Biomarkers and assessment of COPD Year: 2007 Mast cells promote lung vascular remodelling in pulmonary hypertension Source: Eur Respir J 2011; 37: 1400-1410 Year: 2011 Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma Source: Eur Respir J 2011; 38: 679-687 Year: 2011 Functional changes in peripheral blood derived outgrowth endothelial progenitor cells from PAH patients in response to hypoxia Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Post-COVID-19 patients show an increased endothelial progenitor cell production Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Blood outgrowth endothelial cells are senescent and dysfunctional in COPD due to increased DNA damage; implications for endothelial dysfunction Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Bronchial epithelial cells secrete an unknown factor that specifically activate inflammatory cytokine expression from neutrophils and peripheral blood mononuclear cells Source: Annual Congress 2004 - Epithelial cells: critical regulation of pathogenic processes in disease Year: 2004 Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension Source: Eur Respir J 2010; 36: 1302-1314 Year: 2010 Cytokine releasing mucosa-homing T cells are increased in peripheral blood of pulmonary fibrosis patients Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Chymase-positive mast cells are related to the vascular remodelling in asthma Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006